Legislator Giurisprudenza & Legislazione
DE FR IT EN
Analizza in Legislator
3 B 40/17, 3 B 40/17 (3 C 20/18) ECLI:DE:BVerwG:2018:181218B3B40.17.0 Generato dall'IA

Compatibility of statutory pharmaceutical price binding with prohibition of nationality discrimination under Article 3(1) of the Basic Law

Numero d'incarto 3 B 40/17, 3 B 40/17 (3 C 20/18)
Autorità giudiziaria
Giurisdizione Germania (DE)
Data della decisione
Esito del giudizio Accolto (Allowed)
Apri la fonte ufficiale Versione Markdown leggibile dalle macchine (.md)

Sintesi Legislator

Generato dall'IA

The Federal Administrative Court (BVerwG) granted the plaintiff's complaint, allowing the appeal on the ground that the case possesses fundamental significance, and set a provisional amount in dispute for the revision proceedings. The dispute concerns the validity of the statutory price binding for pharmaceuticals applicable to domestic pharmacies, specifically challenging whether this regulation violates the prohibition of discrimination against German nationals in the cross-border provision of healthcare services, as established by the European Court of Justice. The decisive legal question involves the compatibility of the domestic price binding mechanism under § 78 Abs. 1 and 2 of the German Medicines Act (AMG) and § 3 of the Pharmaceuticals Pricing Regulation (AMPreisV) with Article 12(1) of the EU Charter of Fundamental Rights and Article 3(1) of the German Basic Law, following the CJEU's judgment in the Deutsche Parkinson Vereinigung case.

Regesto Legislator

Generato dall'IA

§ 132 Abs. 2 Nr. 1 VwGO, Art. 3 Abs. 1 GG, § 63 Abs. 1 Satz 1 GKG, § 47 Abs. 1, § 52 Abs. 2 und § 63 Abs. 1 Satz 1 GKG; Compatibility of statutory pharmaceutical price binding with prohibition of nationality discrimination under Article 3(1) of the Basic Law: The dispute concerns the validity of the statutory price binding for pharmaceuticals applicable to domestic pharmacies, specifically challenging whether this regulation violates the prohibition of discrimination against German nationals in the cross-border provision of healthcare services, as established by the European Court of Justice. The decisive legal question involves the compatibility of the domestic price binding mechanism under § 78 Abs. 1 and 2 of the German Medicines Act (AMG) and § 3 of the Pharmaceuticals Pricing Regulation (AMPreisV) with Article 12(1) of the EU Charter of Fundamental Rights and Article 3(1) of the German Basic Law, following the CJEU's judgment in the Deutsche Parkinson Vereinigung case.

Parole chiave

Generato dall'IA
divieto di discriminazione diritto legale diritti fondamentali nazionalità importo di base prestazione di servizi

Disposizioni normative citate

Generato dall'IA
§ 132 Abs. 2 Nr. 1 VwGO
The legal basis for granting the complaint and allowing the appeal due to the fundamental significance of the case.
Art. 3 Abs. 1 GG
1, Art. 3 Abs. 1 GG unvereinbar ist.
§ 63 Abs. 1 Satz 1 GKG
2 und § 63 Abs. 1 Satz 1 GKG.
§ 47 Abs. 1, § 52 Abs. 2 und § 63 Abs. 1 Satz 1 GKG
The procedural rules applied to determine the provisional amount in dispute for the revision proceedings.
Generato dall'IA
3 B 41/17, 3 B 41/17 (3 C 21/18)
Statutory pharmacy price binding's compatibility with equal treatment under Art. 3, 12 GG following ECJ ruling on national discrimination
I ZR 74/24
Incompatibility of domestic drug price-binding extended to foreign mail-order pharmacies with EU freedom of goods movement
I ZR 72/08
Extraterritorial application of German pharmaceutical price binding to cross-border mail-order drug sales
3 C 21/18
Validity of domestic pharmaceutical price binding despite EU-wide exemption for foreign mail-order pharmacies
2 BvR 787/16
Extension of German pharmaceutical price binding to foreign online pharmacies: conflict with EU free movement and national constitutional rights

Questioni giuridiche chiave estratte da Legislator

Generato dall'IA
§ 132 Abs. 2 Nr. 1 VwGO

The legal basis for granting the complaint and allowing the appeal due to the fundamental significance of the case.

§ 47 Abs. 1, § 52 Abs. 2 und § 63 Abs. 1 Satz 1 GKG

The procedural rules applied to determine the provisional amount in dispute for the revision proceedings.

Ti chiedi come si applica questa sentenza alla tua fattispecie?

Analizza questa decisione insieme alla legislazione federale e cantonale, ai commentari e alla giurisprudenza successiva in Legislator AI.

Apri in Legislator →

Testo completo

Revisionszulassung; Inländerdiskriminierung; zur Preisbindung von Arzneimitteln für inländische Apotheken

[GRUENDE]

Die Beschwerde der Klägerin hat Erfolg. Der Rechtssache kommt die geltend gemachte grundsätzliche Bedeutung (§ 132 Abs. 2 Nr. 1 VwGO) zu. Das Revisionsverfahren wird dem Bundesverwaltungsgericht voraussichtlich Gelegenheit zur Klärung der Frage geben, ob die für inländische Apotheken geltende Preisbindung für Arzneimittel (§ 78 Abs. 1 und 2 AMG, § 3 AMPreisV) in Folge des Urteils des Gerichtshofs der Europäischen Union vom 19. Oktober 2016 - C-148/15 [ECLI:EU:C:2016:776], Deutsche Parkinson Vereinigung - (NVwZ 2016, 1793) wegen "Inländerdiskriminierung" mit Art. 12 Abs. 1, Art. 3 Abs. 1 GG unvereinbar ist.

Die vorläufige Streitwertfestsetzung für das Revisionsverfahren beruht auf § 47 Abs. 1, § 52 Abs. 2 und § 63 Abs. 1 Satz 1 GKG.